Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2022

Genmab — Januar 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #1224

    Daratumumab for treatment-refractory antibody-mediated diseases in neurology https://onlinelibrary.wiley.com/doi/10.1111/ene.15266

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #1225

      i said last week InnovaTV 205 was already combining with Keytruda , but not Keytruda and chemo together; they now add 1 arm to include that combo, possibly even a quad combination https://clinicaltrials.gov/ct2/history/NCT03786081?A=13&B=14&C=merged#StudyPageTop

      1 Reply Last reply
      0
      • D Offline
        D Offline
        Doublo
        wrote on sidst redigeret af
        #1226

        HC Wainwright co hæver kursen til køb fra neutral og deres kurs på Genmab er. 47$

        1 Reply Last reply
        0
        • D Offline
          D Offline
          Doublo
          wrote on sidst redigeret af
          #1227

          undskyld "gammel nyhed"

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #1228

            Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Bispecific Antibody Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.businesswire.com/news/home/20220128005418/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Bispecific-Antibody-Teclistamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Plimsoller
              wrote on sidst redigeret af
              #1229

              Genmab ligger sørme på 5. pladsen over de største skatteydere i 2021 https://finans.dk/erhverv/ECE13690430/her-er-danmarks-stoerste-skatteydere/?ctxref=ext

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #1230

                Mandagens aktier: C25 badet i grønt med biotek og Vestas i front
                https://www.proinvestor.com/investornyt/773760/mandagens-aktier-c25-badet-i-gront-med-biotek-og-vestas-i-front

                1 Reply Last reply
                0
                • I Offline
                  I Offline
                  Inga_Finnsen
                  wrote on sidst redigeret af
                  #1231

                  Overraskende stille herinde i forhold til at ADS’en er 120kr over fredagens DK luk

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    HHM
                    wrote on sidst redigeret af
                    #1232

                    Ja, Inga, syntes også det er lidt underligt, det har jo faktisk været en OK dag, til en forandring, uden den der siven hen over dagen. Der er stadig langt tilbage til 3100, eller de 4-5-6000 man talte om før da, MEN man håber da på en dag som denne at det dårlig momentum måske er vendt til posetivt momentum.

                    1 Reply Last reply
                    0
                    • H Offline
                      H Offline
                      HHM
                      wrote on sidst redigeret af
                      #1233

                      Bemærkede iøvrigt at de tre mest shortede firmaer i DK alle er biotek, men Genmab er slet ikke på listen, det opfatter jeg som posetivt 🙂 https://shortnordic.com/most_shorted_companies_all.php?country=denmark

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #1234

                        Us fortsætter op. Igen incl nbi.

                        1 Reply Last reply
                        0

                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                        With your input, this post could be even better 💗

                        Tilmeld Log ind
                        Svar
                        • Svar som emne
                        Login for at svare
                        • Ældste til nyeste
                        • Nyeste til ældste
                        • Most Votes


                        • Log ind

                        • Har du ikke en konto? Tilmeld

                        • Login or register to search.
                        Powered by NodeBB Contributors
                        • First post
                          Last post
                        0
                        • Kategorier
                        • Seneste
                        • Etiketter
                        • Populære
                        • Verden
                        • Bruger
                        • Grupper